Venrock Healthcare Capital Partners III, L.P. acquires a 9% stake in Frazier Life Sciences Acquisition Corp. II, signaling growing interest in the blank check sector.
| Name | Frazier Life Sciences Acquisition Corp. II |
|---|---|
| CIK | 0002153598 |
| Tickers | FLSC |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 6770 Blank Checks |
| EIN | 981964369 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | E9 Cayman Islands |
| Phone | 650-325-5156 |
| Website | — |
| Investor website | — |
| Owner org | 01 Energy & Transportation |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Venrock Healthcare Capital Partners III, L.P. acquires a 9% stake in Frazier Life Sciences Acquisition Corp. II, signaling growing interest in the blank check sector.
RA Capital Management, L.P. has disclosed a 9% stake in Frazier Life Sciences Acquisition Corp. II, signaling strong investor interest in the SPAC sector.
Frazier Life Sciences Acquisition Corp. II raises $75 million in its IPO, marking a significant step in the blank check industry.
Deep Track Capital, LP has acquired an 8.97% stake in Frazier Life Sciences Acquisition Corp. II, signaling increased interest in the blank check company sector.
23 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 10-Q | 10-Q | 0001193125-26-465479 | 001-43504 | 261565958 | 34 | 2633109 | 1 | 1 | |
| 2026-10-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001738048-26-000075 | 005-95969 | 261491282 | 34 | 35043 | |||
| 2026-10-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-429129 | 001-43504 | 261479514 | 34 | 255145 | 1 | 1 |
| 2026-10-22 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000245 | 005-95969 | 261478952 | 34 | 18993 | |||
| 2026-10-21 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-428005 | 005-95969 | 261476815 | 34 | 135271 | |||
| 2026-10-21 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-002836 | 005-95969 | 261476783 | 34 | 38555 | |||
| 2026-10-21 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-004630 | 005-95969 | 261475859 | 34 | 13092 | |||
| 2026-10-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-116496 | 005-95969 | 261464741 | 34 | 27267 | |||
| 2026-10-15 | 4 | 4 | 0001193125-26-422957 | 12577 | ||||||
| 2026-10-15 | 8-K | 8-K | 1.01,3.02,5.03,8.01,9.01 | 0001193125-26-422919 | 001-43504 | 261463335 | 34 | 1246533 | 1 | 1 |
| 2026-10-14 | 424B4 | 424B4 | 0001193125-26-421735 | 333-299101 | 261460281 | 33 | 1429576 | |||
| 2026-10-13 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003227 | 333-299101 | 261458196 | 33 | 1809 | ||
| 2026-10-13 | 3 | 3 | 0001193125-26-420812 | 20649 | ||||||
| 2026-10-13 | 3 | 3 | 0001193125-26-420801 | 20920 | ||||||
| 2026-10-13 | 3 | 3 | 0001193125-26-420796 | 23487 | ||||||
| 2026-10-13 | 3 | 3 | 0001193125-26-420791 | 20321 | ||||||
| 2026-10-13 | 3 | 3 | 0001193125-26-420790 | 29077 | ||||||
| 2026-10-13 | 3 | 3 | 0001193125-26-420789 | 19582 | ||||||
| 2026-10-13 | 3 | 3 | 0001193125-26-420782 | 20520 | ||||||
| 2026-10-13 | CERT | 8A_Cert_FLSC_2153598.pdf | 0001354457-26-000983 | 001-43504 | 261456645 | 34 | 181682 | |||
| 2026-10-08 | 8-A12B | 8-A12B | 0001193125-26-417909 | 001-43504 | 261449944 | 34 | 14703 | |||
| 2026-09-24 | S-1 | S-1 | 0001193125-26-399703 | 333-299101 | 261401826 | 33 | 5084563 | 1 | 1 | |
| 2026-09-11 | DRS | filename1.htm | 0001193125-26-389015 | 377-09749 | 261373666 | 33 | 2503242 |
One latest value per concept from companyfacts (48 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ffd | NetFeeAmt | NetFeeAmt | USD | 10,357.5 | 2026-09-23 | S-1 | 2026-09-24 | 0001193125-26-399703 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 10,357.5 | 2026-09-23 | S-1 | 2026-09-24 | 0001193125-26-399703 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 75.00M | 2026-09-23 | S-1 | 2026-09-24 | 0001193125-26-399703 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-23 | S-1 | 2026-09-24 | 0001193125-26-399703 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-09-23 | S-1 | 2026-09-24 | 0001193125-26-399703 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 53,183 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 71,478 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 24,812 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 4.11M | 2026-10-13 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | Assets | Assets | USD | 437,092 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 162,393 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | AssetsHeldInTrust | Assets Held-in-trust | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | Cash | Cash | USD | 162,393 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 162,393 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 162,393 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | DeferredCompensationLiabilityClassifiedNoncurrent | Deferred Compensation Liability, Classified, Noncurrent | USD | 3.00M | 2026-10-13 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.07 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.07 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 87,570 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 524,661 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities | Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 187,392 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -24,999 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -112,569 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 750,000 | 2026-10-13 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 200,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | OtherUnderwritingExpense | Other Underwriting Expense | USD | 1.50M | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | PaymentsToAcquireRestrictedInvestments | Payments to Acquire Restricted Investments | USD | 75.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 1.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 75.00M | 2026-10-13 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 25,000 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 200,000 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -112,569 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 10 | 2026-10-13 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 112,569 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -87,569 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 437,092 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 25,000 | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | TemporaryEquityRedemptionPricePerShare | Temporary Equity, Redemption Price Per Share | USD/shares | 10 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 1.70M | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 1.70M | 2026-08-07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-17 | 0001193125-26-465479 |